Befotertinib is a chemical compound under investigation as an active pharmaceutical ingredient. It is being studied in clinical trials for advanced EGFR-mutant lung cancer.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1835667-63-4
오시머티닙
active pharmaceutical ingredient
Osimertinib mesylate
active pharmaceutical ingredient
ETHACRIDINE LACTATE
active pharmaceutical ingredient
Formoterol fumarate dihydrate
active pharmaceutical ingredient
Pyrilamine tannate
antihistamine active pharmaceutical ingredient
Salcaprozic acid
oral absorption promoter
Mobocertinib
active pharmaceutical ingredient
Mobocertinib succinate
active pharmaceutical ingredient
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide
USOCZVZOXKTJTI-UHFFFAOYSA-N
CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)CC(F)(F)F)OC